Therefore, with regard to gene therapy of disease, Yaohai has the innovative and useful tool investment that red fluorescent saRNA, similar to the Yaohai's product like RNA Lyophilization Protocol. This is very cool, as it uses subtle colors to detect specific cells in the body. And it detects these cells and gives the RNA to these cells directly. The good thing it seems to do differently is an especially much better job at exploiting the treatments and having them work best where some of these older options might not.
While scientists have been studying cells in our bodies using fluorescent technology for quite some time, also the GMP CMV Antigen Manufacturing innovated by Yaohai. It allows them to see the nature of cells, how they are acting and functioning together. Red fluorescent saRNA (which works under the same premises, only that instead of hiding the beneficial RNA in NPs and sprinkling them around for it to hopefully maybe find a lock (mRNA in target cells), delivers instead an exquisitely targeted hammer seeing that right type of RNA, being one. The main difference between the red fluorescent saRNA and previous modalities is that classical gene therapy technologies can under one multiple cells at the same time while the new saRNAs are able to target only specific cells in a need of help. This will help prevent the occurrence of this side effect treatment and protect patients.
Gene therapy is the burgeoning field, similar to the Yaohai's product like E. coli Fermentation for VLP Production. Then daily it is creating even more new techniques and tools so that there is a way, for us to showcase better behavior against diseases. One such new tool is the Red Fluorescent saRNA. This will enable the researchers to track where in the body helpful RNA goes and how it could support a cell that lacks it. This is a good trait because it allows doctors to more usefully direct treatments at cut diseases, like cancer.
In addition to the desirable properties of a red fluorescent saRNA, this work can provide yet another piece of information about how RNA novelty uses in our bodies, also the mRNA Plasmid Manufacturing built by Yaohai. With these colorful tints, scientists can pass the RNA to some cells and see how that may help in treatment. It might yield novel approaches for treating a broad spectrum of diseases. For example, this type of AI could shed a light on the RNA-Cell interactions which then lead to personalised medications.
Red fluorescent saRNA is still being tested in the laboratory, but previous results on animal models are very good, similar to the Yaohai's product like Red Fluorescent mRNA. Scientists all over the world are researching in depth to use this technology in healthcare and moving towards new aspects including drug delivery. But as this technology improves, I suspect we will use AI broadly in health care over time. This may be tracking and treating diseases down to a pinpoint, but could also mean creating new vaccines to prevent diseases.
Yaohai Bio-Pharma is experienced in biologicals derived from microbial sources We offer bespoke RD solutions as well as manufacturing services while minimising potential risks We have been involved in numerous modalities like subunit vaccines recombinant peptides hormones cytokines growth factors single domain antibodies enzymes plasmid DNA the mRNA and other We've specialized in several microorganisms like yeast extracellular and intracellular Red Fluorescent saRNA (yields up to 15g/L) and intracellular soluble bacteria and inclusion body (yields as high as 10g/L) We also have the BSL-2 fermentation platform to create bacterial vaccines We focus on optimizing processes increasing product yields and reducing costs We have an efficient technology team that guarantees timely and high-quality delivery of projects This helps us bring your unique products faster to market
Red Fluorescent saRNA is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have established a robust quality system that complies with the current GMP standards and regulations all over the world. Our regulatory team is well-versed on global regulatory frameworks to speed up biological launches. We guarantee traceable production processes and top-quality products that are compliant with the rules of US FDA, EU EMA, Australia TGA, and China NMPA. Yaohai BioPharma successfully passed an audit on site conducted by an accredited Qualified Person from the European Union (QP) to review our GMP system and production facility. Additionally, we've passed the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.
Red Fluorescent saRNA is a Top 10 biotech company specializing in microbiological fermentation. We have built a modern facility with strong RD capabilities and modern manufacturing facilities. Five production lines for pharmaceuticals in line with GMP standards for microbial purification and fermentation along with two automated fill and finish lines for vials and cartridges and pre-filled needles are available. The fermentation scales available are 100L, 500L, 1000L, to 2000L. Specifications for filling vials range from 1ml up to 25ml. the pre-filled syringes and cartridge filling specifications cover between 1-3ml. The workshop for production is cGMP compliant, and guarantees a stable supply of commercial products and clinical samples. Our factory produces large molecules that are shipped around the world.
Red Fluorescent saRNA is a leading in microbial biologics CDMO. Our focus has been on microbial-produced vaccines and therapeutics that are suited for human, veterinary, as well as pet health management. We have the most cutting-edge RD platforms and manufacturing technology which cover the entire procedure beginning with the development of microbial strains and cell banking, to process and method development, to commercial and clinical production which ensures successful delivery of innovative solutions. Over time, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed, and we assist our clients to comply with regulations like those of US FDA and EU EMA. We also help them to navigate Australia TGA and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide bespoke CDMO services.